Sign in
4

Changes in Ownership

Scribe Therapeutics, Inc. Filed Acc 0000902664-26-003254

Options or other derivatives

  • Director acquired 14,725 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Aghazadeh Behzad Director 2026-07-23 Grant or award · Stock Option (Right to Buy) +14,725 14,725 D
Loading xslF345X06/ownership.xml…